OpenBilldrug price receipt

NADAC week of 2026-10-14

PRAVASTATIN SODIUM 20 MG TAB

For 30 tablets

Pharmacies pay

$1.74 filed

30 × $0.05797 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$5.41 filed

30 × $0.18035 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.1× estimated

Medicare paid 3.1× what pharmacies pay.

Part D averages every strength and form sold under “Pravastatin Sodium” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$7.00 estimated

$1.74 + $0.26 (15%) + $5.00 fee per fill = $7.00

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

PRAVASTATIN SODIUM 20 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as pravastatin sodium.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and NorthStar RxLLC.

FDA’s Established Pharmacologic Class for it is HMG-CoA Reductase Inhibitor.

The NADAC file of 2026-10-14 prices it under 21 NDCs (National Drug Codes); the FDA directory lists 17 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.74 for 30 tablets (30 × $0.05797 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 11 labelers

LabelerNDCsPharmacies pay per unit
Apotex Corp.2$0.05797 per EA filed
Aurobindo Pharma Limited2$0.05797 per EA filed
Biocon Pharma Inc.2$0.05797 per EA filed
CIPLA USA INC.2$0.05797 per EA filed
Glenmark Pharmaceuticals Inc., USA2$0.05797 per EA filed
NorthStar RxLLC2$0.05797 per EA filed
American Health Packaging1$0.05797 per EA filed
AvPAK1$0.05797 per EA filed
Major Pharmaceuticals1$0.05797 per EA filed
Quallent1$0.05797 per EA filed
Teva Pharmaceuticals USA, Inc.1$0.05797 per EA filed
Not listed as a package in the FDA directory4$0.05797 per EA filed
All 21 NDCs, with labeler and price
  • 00093-7201-10 · Teva Pharmaceuticals USA, Inc. · $0.05797 per EA · eff. 2026-09-23 filed
  • 00904-5892-61 · Major Pharmaceuticals · $0.05797 per EA · eff. 2026-09-23 filed
  • 16714-0559-01 · NorthStar RxLLC · $0.05797 per EA · eff. 2026-09-23 filed
  • 16714-0559-02 · NorthStar RxLLC · $0.05797 per EA · eff. 2026-09-23 filed
  • 24689-0141-02 · not listed as a package in the FDA directory · $0.05797 per EA · eff. 2026-09-23 filed
  • 24689-0141-05 · not listed as a package in the FDA directory · $0.05797 per EA · eff. 2026-09-23 filed
  • 50268-0666-11 · not listed as a package in the FDA directory · $0.05797 per EA · eff. 2026-09-23 filed
  • 50268-0666-15 · AvPAK · $0.05797 per EA · eff. 2026-09-23 filed
  • 60505-0169-07 · Apotex Corp. · $0.05797 per EA · eff. 2026-09-23 filed
  • 60505-0169-09 · Apotex Corp. · $0.05797 per EA · eff. 2026-09-23 filed
  • 60687-0897-01 · American Health Packaging · $0.05797 per EA · eff. 2026-09-23 filed
  • 60687-0897-11 · not listed as a package in the FDA directory · $0.05797 per EA · eff. 2026-09-23 filed
  • 68462-0196-05 · Glenmark Pharmaceuticals Inc., USA · $0.05797 per EA · eff. 2026-09-23 filed
  • 68462-0196-90 · Glenmark Pharmaceuticals Inc., USA · $0.05797 per EA · eff. 2026-09-23 filed
  • 69097-0789-05 · CIPLA USA INC. · $0.05797 per EA · eff. 2026-09-23 filed
  • 69097-0789-12 · CIPLA USA INC. · $0.05797 per EA · eff. 2026-09-23 filed
  • 70377-0046-12 · Biocon Pharma Inc. · $0.05797 per EA · eff. 2026-09-23 filed
  • 70377-0046-14 · Biocon Pharma Inc. · $0.05797 per EA · eff. 2026-09-23 filed
  • 82009-0006-10 · Quallent · $0.05797 per EA · eff. 2026-09-23 filed
  • 84386-0032-90 · Aurobindo Pharma Limited · $0.05797 per EA · eff. 2026-09-23 filed
  • 84386-0032-99 · Aurobindo Pharma Limited · $0.05797 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name pravastatin sodium with PRAVASTATIN SODIUM 20 MG TAB.

ProductPharmacies pay per unitMedicare per unit
PRAVASTATIN SODIUM 10 MG TAB
generic · tablet
$0.05549 per EA filed
eff. 2026-09-23
$0.18035 per EA filed
Part D 2024 average
PRAVASTATIN SODIUM 20 MG TAB this page
generic · tablet
$0.05797 per EA filed
eff. 2026-09-23
$0.18035 per EA filed
Part D 2024 average
PRAVASTATIN SODIUM 40 MG TAB
generic · tablet
$0.0828 per EA filed
eff. 2026-09-23
$0.18035 per EA filed
Part D 2024 average
PRAVASTATIN SODIUM 80 MG TAB
generic · tablet
$0.14329 per EA filed
eff. 2026-09-23
$0.18035 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 21 NDCs’ NADAC prices is $0.05797 per EA filed.

Of the 56 other products in FDA’s HMG-CoA Reductase Inhibitor class priced per EA, 42 have a higher middle NADAC price and 14 a lower one. The one in the middle is AMLODIPINE-ATORVAST 10-10 MG, at $0.97947 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $5.41 for 30 tablets, at an average of $0.18035 per EA in 2024 (2024-01-01 to 2024-12-31) for “Pravastatin Sodium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 9,395,079 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for PRAVASTATIN SODIUM 20 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Pravastatin Sodium / Pravastatin Sodium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.